Atlas company financials

Elevance Health, Inc.

Standardized 19-year financial series for Elevance Health, Inc., built from filing-derived source data and exposed in JSON, CSV, and XLSX so it can feed iterFact artifacts or analyst workflows without hand-entering the numbers.

United StatesCIK 0001156039FY2007 → FY2025

Open JSON Download CSV Download XLSX Quarterly JSON Summary JSON Filing index

Latest fiscal year

FY2025

Revenue

$199.1B

Adjusted EBITDA

—

Net result

$5.7B

Net financial debt

$22.6B

Latest source: FY2025 filing · published data snapshot generated April 26, 2026

Phase 2 summary

Latest quarter, TTM, and growth are now pre-computed for chat and templates.

Latest quarter revenue

$50.2B

TTM revenue

$199.6B

TTM free cash flow

—

Latest quarter net result

$1.8B

Quarterly coverage: 54 periods · latest quarter FY2026-Q1 · TTM revenue growth 14.4%.

What this gives you

A proof-of-concept company data surface, not a dead PDF shelf.

The same standardized payload behind this page is exposed through downloadable CSV and XLSX files plus a stable JSON route. That makes it usable as a live input to iterFact templates, a spreadsheet handoff, or a future API surface without re-normalizing the source documents again.

Source audit

Official links first, raw iterFact payloads right next to them.

Official sources

SEC EDGAR companyfacts
comparative · elevance-health-inc-fy2007 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2010-02-18 · Retrieved: 2026-04-26T11:40:10.203670+00:00
SEC EDGAR companyfacts
us-gaap:OperatingIncomeLoss · us gaap companyfacts · comparative · elevance-health-inc-fy2008 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2011-02-17 · Retrieved: 2026-04-26T11:40:10.203670+00:00
SEC EDGAR companyfacts
us-gaap:CostOfGoodsSold · us gaap companyfacts · comparative · elevance-health-inc-fy2010 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2013-02-22 · Retrieved: 2026-04-26T11:40:10.203670+00:00
SEC EDGAR companyfacts
primary · elevance-health-inc-fy2011 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2012-02-22 · Retrieved: 2026-04-26T11:40:10.203670+00:00
SEC EDGAR companyfacts
primary · elevance-health-inc-fy2013 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2014-02-20 · Retrieved: 2026-04-26T11:40:10.203670+00:00

Ten-year series

Headline company financials by fiscal year

Fiscal year	Revenue	Adj. EBITDA	EBIT	Net result	Op. cash flow	Capex	Net debt	Status
FY2007	61B	—	—	3B	4B	-322M	—	comparative annual fact carried from later 10k · missing accounts receivable · missing adjusted ebitda · missing current assets · missing current liabilities · missing diluted weighted average shares · missing ebit · missing gross profit · missing inventory · missing net financial debt · missing research and development · missing total assets
FY2008	61B	—	4B	2B	3B	-346M	7B	comparative annual fact carried from later 10k · missing accounts receivable · missing adjusted ebitda · missing gross profit · missing inventory · missing research and development
FY2009	65B	—	4B	5B	3B	-378M	4B	missing accounts receivable · missing adjusted ebitda · missing gross profit · missing inventory · missing research and development
FY2010	59B	—	4B	3B	1B	-451M	7B	missing accounts receivable · missing adjusted ebitda · missing gross profit · missing inventory · missing research and development
FY2011	61B	—	4B	3B	3B	-520M	8B	missing accounts receivable · missing adjusted ebitda · missing gross profit · missing inventory · missing research and development
FY2012	62B	—	4B	3B	3B	-545M	12B	missing accounts receivable · missing adjusted ebitda · missing gross profit · missing inventory · missing research and development
FY2013	71B	—	4B	2B	3B	-647M	13B	missing accounts receivable · missing adjusted ebitda · missing cost of revenue · missing gross profit · missing inventory · missing research and development

Filing provenance